Wall Street brokerages forecast that Medidata Solutions Inc (NASDAQ:MDSO) will report $0.38 earnings per share (EPS) for the current quarter, according to Zacks. Seven analysts have made estimates for Medidata Solutions’ earnings. The lowest EPS estimate is $0.33 and the highest is $0.42. Medidata Solutions reported earnings of $0.31 per share in the same quarter last year, which indicates a positive year over year growth rate of 22.6%. The firm is expected to report its next earnings results on Tuesday, July 17th.
According to Zacks, analysts expect that Medidata Solutions will report full-year earnings of $1.53 per share for the current fiscal year, with EPS estimates ranging from $1.49 to $1.56. For the next financial year, analysts expect that the company will post earnings of $1.96 per share, with EPS estimates ranging from $1.80 to $2.09. Zacks Investment Research’s EPS averages are an average based on a survey of analysts that follow Medidata Solutions.
Medidata Solutions (NASDAQ:MDSO) last posted its quarterly earnings data on Thursday, April 19th. The company reported $0.40 EPS for the quarter, beating the Zacks’ consensus estimate of $0.35 by $0.05. Medidata Solutions had a net margin of 7.96% and a return on equity of 11.36%. The company had revenue of $149.20 million for the quarter, compared to analyst estimates of $146.73 million. During the same period in the prior year, the firm posted $0.31 EPS. The company’s quarterly revenue was up 16.9% on a year-over-year basis.
A number of equities research analysts have recently commented on MDSO shares. Zacks Investment Research lowered shares of Medidata Solutions from a “hold” rating to a “sell” rating in a research note on Thursday, April 12th. ValuEngine lowered shares of Medidata Solutions from a “hold” rating to a “sell” rating in a research note on Saturday, March 17th. Piper Jaffray Companies upped their price objective on shares of Medidata Solutions to $98.00 and gave the company an “overweight” rating in a research note on Wednesday, May 23rd. Morgan Stanley lowered shares of Medidata Solutions from an “overweight” rating to a “hold” rating and set a $79.00 price objective on the stock. in a research note on Monday, May 21st. Finally, Deutsche Bank upped their price objective on shares of Medidata Solutions from $78.00 to $85.00 and gave the company a “buy” rating in a research note on Thursday, May 31st. One investment analyst has rated the stock with a sell rating, five have given a hold rating and eleven have assigned a buy rating to the company’s stock. The stock currently has an average rating of “Buy” and a consensus target price of $86.07.
In other Medidata Solutions news, EVP Michael I. Otner sold 10,395 shares of the company’s stock in a transaction on Wednesday, April 25th. The shares were sold at an average price of $70.05, for a total transaction of $728,169.75. Following the transaction, the executive vice president now owns 74,165 shares in the company, valued at $5,195,258.25. The transaction was disclosed in a filing with the SEC, which is accessible through this link. Also, CFO Rouven Bergmann sold 4,000 shares of the company’s stock in a transaction on Thursday, April 19th. The stock was sold at an average price of $71.50, for a total transaction of $286,000.00. Following the transaction, the chief financial officer now owns 93,744 shares in the company, valued at approximately $6,702,696. The disclosure for this sale can be found here. Over the last three months, insiders have sold 24,025 shares of company stock worth $1,774,961. 4.70% of the stock is owned by insiders.
Institutional investors and hedge funds have recently added to or reduced their stakes in the business. Massachusetts Financial Services Co. MA acquired a new position in Medidata Solutions during the first quarter worth $14,028,000. New Mexico Educational Retirement Board acquired a new position in Medidata Solutions during the fourth quarter worth $919,000. Quadrature Capital Ltd acquired a new position in Medidata Solutions during the fourth quarter worth $992,000. Deutsche Bank AG raised its holdings in Medidata Solutions by 10.5% during the fourth quarter. Deutsche Bank AG now owns 278,714 shares of the company’s stock worth $17,659,000 after buying an additional 26,425 shares during the last quarter. Finally, Teacher Retirement System of Texas raised its holdings in Medidata Solutions by 317.5% during the fourth quarter. Teacher Retirement System of Texas now owns 20,020 shares of the company’s stock worth $1,269,000 after buying an additional 15,225 shares during the last quarter.
Shares of NASDAQ:MDSO traded up $1.40 during trading on Friday, reaching $80.56. The stock had a trading volume of 995,265 shares, compared to its average volume of 555,913. The company has a debt-to-equity ratio of 0.18, a quick ratio of 1.63 and a current ratio of 1.63. Medidata Solutions has a 52 week low of $59.60 and a 52 week high of $85.92. The firm has a market cap of $4.69 billion, a P/E ratio of 94.78, a P/E/G ratio of 5.08 and a beta of 1.50.
About Medidata Solutions
Medidata Solutions, Inc provides cloud-based solutions for life sciences worldwide. It offers the Medidata Clinical Cloud, a platform, pioneering analytics, and clinical technology for the development of new therapies. The company's platform solutions include data capture and management and trial planning and management.
Get a free copy of the Zacks research report on Medidata Solutions (MDSO)
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Medidata Solutions Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Medidata Solutions and related companies with MarketBeat.com's FREE daily email newsletter.